Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Issued (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Shares Issued for 4 consecutive years, with $91000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Shares Issued rose 405.56% to $91000.0 in Q1 2025 year-over-year; TTM through Sep 2025 was $142000.0, a 5.97% increase, with the full-year FY2024 number at $240000.0, up 943.48% from a year prior.
  • Shares Issued was $91000.0 for Q1 2025 at Orchestra BioMed Holdings, up from $51000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $171000.0 in Q2 2024 to a low of -$55000.0 in Q4 2023.
  • A 4-year average of $43181.8 and a median of $42000.0 in 2022 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: plummeted 75.93% in 2023, then skyrocketed 1215.38% in 2024.
  • Orchestra BioMed Holdings' Shares Issued stood at $42000.0 in 2022, then tumbled by 230.95% to -$55000.0 in 2023, then soared by 192.73% to $51000.0 in 2024, then surged by 78.43% to $91000.0 in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Shares Issued are $91000.0 (Q1 2025), $51000.0 (Q4 2024), and $171000.0 (Q2 2024).